Salivary gland involvement in chronic graft-versus-host disease: Prevalence, clinical significance, and recommendations for evaluation

Biology of Blood and Marrow Transplantation

Volumn 16, Issue 10, 2010, Pages 1362-1369

  Imanguli, Matin M ^a   Atkinson, Jane C ^b   Mitchell, Sandra A ^c   Avila, Daniele N ^a   Bishop, Rachel J ^d   Cowen, Edward W ^a   Datiles, Manuel B ^d   Hakim, Frances T ^a   Kleiner, David E ^a   Krumlauf, Michael C ^a   Pavletic, Steven Z ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d NATIONAL EYE INSTITUTE   (United States)

Author keywords

CGVHD; Sicca syndrome; Sjogren's syndrome; Xerophthalmia; Xerostomia

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

APLASTIC ANEMIA; ARTICLE; ATROPHY; BODY MASS; CELL INFILTRATION; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC LEUKEMIA; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DRY EYE; FEMALE; FIBROSIS; FLOW RATE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LACRIMAL GLAND DISEASE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; MOUTH CAVITY; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; MYELOFIBROSIS; OUTCOME ASSESSMENT; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; QUALITY OF LIFE; SALIVARY GLAND DISEASE; SALIVATION; SJOEGREN SYNDROME; XEROPHTHALMIA; XEROSTOMIA;

ADULT; AGED; BIOPSY; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LACRIMAL APPARATUS; MALE; MIDDLE AGED; PREVALENCE; SALIVARY GLANDS; SALIVARY GLANDS, MINOR; SALIVATION; SINGLE-BLIND METHOD; STOMATITIS; XEROPHTHALMIA; XEROSTOMIA; YOUNG ADULT;

EID: 77956276147     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2010.03.023     Document Type: Article

References (31)

1. Baird K., Pavletic S.Z. Chronic graft-versus-host disease. Curr Opin Hematol 2006, 13:426-435.
2. Mathews S.A., Kurien B.T., Scofield R.H. Oral manifestations of Sjogren's syndrome. J Dent Res 2008, 87:308-318.
3. Sakaida E., Nakaseko C., Harima A., et al. Late-onset noninfectious pulmonary complications after allogeneic stem cell transplantation are significantly associated with chronic graft-versus-host disease and with the graft-versus-leukemia effect. Blood 2003, 102:4236-4242.
4. Tichelli A., Duell T., Weiss M., et al. Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: incidence and risk factors. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Late Effects. Bone Marrow Transplant 1996, 17:1105-1111.
5. Flowers M.E., Parker P.M., Johnston L.J., et al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood 2002, 100:415-419.
6. Mohty M., Kuentz M., Michallet M., et al. Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study. Blood 2002, 100:3128-3134.
7. Schubert M.M., Sullivan K.M. Recognition, incidence, and management of oral graft-versus-host disease. NCI Monogr 1990, 135-143.
8. Lee S.J., Vogelsang G., Flowers M.E. Chronic graft-versus-host disease. Biol Blood Marrow Transplant 2003, 9:215-233.
9. Filipovich A.H., Weisdorf D., Pavletic S., et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease, I: diagnosis and staging working group report. Biol Blood Marrow Transplant 2005, 11:945-956.
10. Pavletic S.Z., Martin P., Lee S.J., et al. Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease IV: Response Criteria Working Group report. Biol Blood Marrow Transplant 2006, 12:252-266.
11. Vitali C., Bombardieri S., Jonsson R., et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002, 61:554-558.
12. Fox P.C., Busch K.A., Baum B.J. Subjective reports of xerostomia and objective measures of salivary gland performance. J Am Dent Assoc 1987, 115:581-584.
13. Navazesh M., Christensen C., Brightman V. Clinical criteria for the diagnosis of salivary gland hypofunction. J Dent Res 1992, 71:1363-1369.
14. Piboonniyom S.O., Treister N., Pitiphat W., et al. Scoring system for monitoring oral lichenoid lesions: a preliminary study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005, 99:696-703.
15. Hegarty A.M., McGrath C., Hodgson T.A., et al. Patient-centered outcome measures in oral medicine: are they valid and reliable?. Int J Oral Maxillofac Surg 2002, 31:670-674.
16. Cella D.F., Tulsky D.S., Gray G., et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 1993, 11:570-579.
17. Lee S., Cook E.F., Soiffer R., et al. Development and validation of a scale to measure symptoms of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2002, 8:444-452.
18. Stewart C.M., Bhattacharyya I., Berg K., et al. Labial salivary gland biopsies in Sjogren's syndrome: still the gold standard?. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008, 106:392-402.
19. Greenspan J.S., Daniels T.E., Talal N., et al. The histopathology of Sjogren's syndrome in labial salivary gland biopsies. Oral Surg Oral Med Oral Pathol 1974, 37:217-229.
20. Sreebny L.M., Valdini A. Xerostomia, part I: relationship to other oral symptoms and salivary gland hypofunction. Oral Surg Oral Med Oral Pathol 1988, 66:451-458.
21. Drummond J.R., Chisholm D.M. A qualitative and quantitative study of the ageing human labial salivary glands. Arch Oral Biol 1984, 29:151-155.
22. Avouac J., Sordet C., Depinay C., et al. Systemic sclerosis-associated Sjogren's syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients. Arthritis Rheum 2006, 54:2243-2249.
23. Taylor D.C., Cripps A.W., Clancy R.L. A possible role for lysozyme in determining acute exacerbation in chronic bronchitis. Clin Exp Immunol 1995, 102:406-416.
24. Loughran T.P., Sullivan K., Morton T., et al. Value of day 100 screening studies for predicting the development of chronic graft-versus-host disease after allogeneic bone marrow transplantation. Blood 1990, 76:228-234.
25. Shulman H.M., Kleiner D., Lee S.J., et al. Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease II: Pathology Working Group report. Biol Blood Marrow Transplant 2006, 12:31-47.
26. Jacobsohn D.A., Margolis J., Doherty J., et al. Weight loss and malnutrition in patients with chronic graft-versus-host disease. Bone Marrow Transplant 2002, 29:231-236.
27. Sale G.E., Shulman H.M., Schubert M.M., et al. Oral and ophthalmic pathology of graft-versus-host disease in man: predictive value of the lip biopsy. Hum Pathol 1981, 12:1022-1030.
28. Horn T.D., Rest E.B., Mirenski Y., et al. The significance of oral mucosal and salivary gland pathology after allogeneic bone marrow transplantation. Arch Dermatol 1995, 131:964-965.
29. Hiroki A., Nakamura S., Shinohara M., et al. A comparison of glandular involvement between chronic graft-versus-host disease and Sjogren's syndrome. Int J Oral Maxillofac Surg 1996, 25:298-307.
30. Calissendorff B., el Azazi M., Lonnqvist B. Dry eye syndrome in long-term follow-up of bone marrow-transplanted patients. Bone Marrow Transplant 1989, 4:675-678.
31. Chaushu G., Itzkovitz-Chaushu S., Yefenof E., et al. A longitudinal follow-up of salivary secretion in bone marrow transplant patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995, 79:164-169.